Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Clear Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05498597
What this trial is testing

AMT-151 in Patients With Selected Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorAdvanced CancerAdvanced Carcinoma+16 more
Multitude Therapeutics Inc. 30
Large-scale testing (Phase 3)Study completedNCT00951496
What this trial is testing

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+35 more
National Cancer Institute (NCI) 1,560
Testing effectiveness (Phase 2)Study completedNCT01715935
What this trial is testing

Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus

Who this might be right for
Clear-cell Renal CarcinomaClear-cell Metastatic Renal Cell Carcinoma
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie 25
Early research (Phase 1)Study completedNCT02575222
What this trial is testing

Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Early research (Phase 1)Looking for participantsNCT05542407
What this trial is testing

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Who this might be right for
Endometrial CancerMetastasisEndometrioid Endometrial Cancer+5 more
UNC Lineberger Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Looking for participantsNCT05287945
What this trial is testing

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Oncorena AB 75
Not applicableEnded earlyNCT01275664
What this trial is testing

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

Who this might be right for
Nausea and VomitingOvarian Brenner TumorOvarian Clear Cell Cystadenocarcinoma+24 more
Gynecologic Oncology Group 4
Testing effectiveness (Phase 2)Study completedNCT00820898
What this trial is testing

Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+1 more
Gynecologic Oncology Group 24
Testing effectiveness (Phase 2)Study completedNCT00408902
What this trial is testing

Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT00550277
What this trial is testing

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

Who this might be right for
Renal Cell Carcinoma
SCRI Development Innovations, LLC 20
Not applicableUnknownNCT06237946
What this trial is testing

Early-stage Ovarian Clear Cell Carcinoma (OCCC) Patients at Risk of Recurrence

Who this might be right for
FIGO Stage IC2 to II Ovarian Clear Cell Carcinoma
National Taiwan University Hospital 272
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Early research (Phase 1)Ended earlyNCT04438083
What this trial is testing

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)

Who this might be right for
Renal Cell Carcinoma
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT01217931
What this trial is testing

Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Study completedNCT00324870
What this trial is testing

Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Ended earlyNCT00561912
What this trial is testing

Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Ended earlyNCT00491075
What this trial is testing

Pemetrexed Plus Gemcitabine in Renal Cell Cancer

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT03108066
What this trial is testing

MK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK-3795-003)

Who this might be right for
VHL Gene MutationVHLVHL Syndrome+8 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 4
Testing effectiveness (Phase 2)Ended earlyNCT00131651
What this trial is testing

ATN-161 in Advanced Renal Cell Cancer

Who this might be right for
Carcinoma, Renal Cell
Attenuon 36
Early research (Phase 1)Study completedNCT01672775
What this trial is testing

Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology

Who this might be right for
Carcinoma, Renal CellRenal Cell Carcinoma of Papillary HistologyRenal Cell Carcinoma With Clear Cell Histology+1 more
Agensys, Inc. 34
Next Page